1-6 of 6
ROSS BRAY
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

728-P: Glycemic Variability of Tirzepatide vs. Insulin Degludec in People with Type 2 Diabetes Using Continuous Glucose Monitoring (SURPASS-3 CGM)

RICHARD M. BERGENSTAL, AMY BARTEE, MELTEM ZEYTINOGLU, ROSS BRAY, SHERYL ALLEN, KATELYN BROWN
Journal: Diabetes
Diabetes 2022;71(Supplement_1):728-P
DOI: https://doi.org/10.2337/db22-728-P
Published: 01 June 2022
View article
Meeting Abstracts

78-LB: Efficacy and Safety of Tirzepatide, a Dual GIP/GLP-1 Receptor Agonist, Compared with Insulin Degludec in Patients with Type 2 Diabetes (SURPASS-3)

BERNHARD LUDVIK, FRANCESCO GIORGINO, ESTEBAN JODAR, JUAN PABLO FRIAS, LAURA FERNANDEZ LANDO, KATELYN BROWN, ROSS BRAY, ÁNGEL RODRÍGUEZ
Journal: Diabetes
Diabetes 2021;70(Supplement_1):78-LB
DOI: https://doi.org/10.2337/db21-78-LB
Published: 01 June 2021
View article
Meeting Abstracts

106-OR: A First-in-Human Single Ascending Dose Study of Oxyntomodulin Analog LY3305677 in Healthy Subjects

LAI-SAN THAM, MELISSA K. THOMAS, CHARLES BENSON, ROSS BRAY, CHENG CAI TANG, CORINA LOGHIN
Journal: Diabetes
Diabetes 2021;70(Supplement_1):106-OR
DOI: https://doi.org/10.2337/db21-106-OR
Published: 01 June 2021
View article
Meeting Abstracts

134-OR: Effects of Tirzepatide (TZP), a Novel Dual GIP and GLP-1 Receptor Agonist, on Biomarkers of Nonalcoholic Steatohepatitis (NASH) in Patients with T2D

MARK L. HARTMAN, ARUN SANYAL, ROHIT LOOMBA, JONATHAN M. WILSON, ROSS BRAY, AMIR NIKOOIENEJAD, KEVIN L. DUFFIN, DEBORAH A. ROBINS, AXEL HAUPT
Journal: Diabetes
Diabetes 2019;68(Supplement_1):134-OR
DOI: https://doi.org/10.2337/db19-134-OR
Published: 01 June 2019
View article
Meeting Abstracts

980-P: Tirzepatide, a Dual GIP and GLP-1 Receptor Agonist, Improves Markers of Beta-Cell Function and Insulin Sensitivity in Type 2 Diabetes Patients

MELISSA K. THOMAS, AMIR NIKOOIENEJAD, ROSS BRAY, XUEWEI CUI, JONATHAN M. WILSON, KEVIN L. DUFFIN, ZVONKO MILICEVIC, AXEL HAUPT, DEBORAH A. ROBINS
Journal: Diabetes
Diabetes 2019;68(Supplement_1):980-P
DOI: https://doi.org/10.2337/db19-980-P
Published: 01 June 2019
View article
Meeting Abstracts

993-P: A 12-Week, Randomized, Placebo-Controlled Study Assessing the Efficacy and Safety of Three Dose-Escalation Algorithms of Tirzepatide, a Novel Dual GIP and GLP-1 Receptor Agonist, in Patients with Type 2 Diabetes

JUAN P. FRIAS, MICHAEL A. NAUCK, JOANNA VAN, CHARLES BENSON, ROSS BRAY, ZVONKO MILICEVIC, AXEL HAUPT, DEBORAH A. ROBINS
Journal: Diabetes
Diabetes 2019;68(Supplement_1):993-P
DOI: https://doi.org/10.2337/db19-993-P
Published: 01 June 2019
View article